Amgen (AMGN.US) Q3 revenue and profit exceed expectations and full-year guidance raised

According to information obtained by Zhihui Finance APP, Amgen (AMGN.US) released its Q3 2026 earnings report after the US stock market closed on November 3: Total revenue was $10.365 billion, up 8% year-on-year and higher than the market's estimate of about $10.05 billion; non-GAAP earnings per share were $6.45, up 14% year-on-year and significantly higher than the estimated $5.77; GAAP earnings per share were $7.08, up 19% year-on-year.